Cite
HARVARD Citation
Goldschmidt, N. et al. (2019). Addition of high-dose methotrexate to standard treatment for patients with high-risk diffuse large B-cell lymphoma contributes to improved freedom from progression and survival but does not prevent central nervous system relapse. Leukemia & lymphoma. 60 (8), pp. 1890-1898. [Online].